Carly Kenselaar

Carly Kenselaar serves as the Senior Director of Competitive Intelligence in Oncology R&D at AstraZeneca, a position held since March 2024. Previously, Carly accumulated extensive experience at Citi from June 2018 to February 2024, advancing from Equity Research Intern to Equity Research Associate, and ultimately to Equity Research Analyst and Senior Associate in the Biotech sector. Prior to that, Carly gained experience as a Finance Intern at Johnson & Johnson during the summer of 2017. Carly holds a Bachelor’s Degree in Finance and Mathematics from Rutgers University.